insights_auto
Why is KLRS down 5,26%?
Dive Deeperchevron_right
KLRS:NASDAQ
Kalaris Therapeutics Inc
US$2,70
arrow_downward
-5,26%(-0,15) 1D
US$2,70
0,00% (0,00)
bedtimeAfter hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLRS...
Open
US$2,90
High
US$2,90
Low
US$2,51
Mkt. cap
64,27 ລ້ານ
Avg. vol.
64,48 ພັນ
Volume
235,90 ພັນ
52-wk high
US$11,88
52-wk low
US$2,51
EPS
US$-2,09
Beta
0,42
Shares outstanding
23,80 ລ້ານ
No. of employees
20
Open
US$2,90
High
US$2,90
Low
US$2,51
Mkt. cap
64,27 ລ້ານ
Avg. vol.
64,48 ພັນ
Volume
235,90 ພັນ
52-wk high
US$11,88
52-wk low
US$2,51
EPS
US$-2,09
Beta
0,42
Shares outstanding
23,80 ລ້ານ
No. of employees
20
News stories
From web sources and news partners
MarketBeat
·
10 ນາທີກ່ອນ
Karooooo Ltd. (NASDAQ:KARO) Receives Consensus Rating of "Moderate Buy" from Brokerages
RealClearMarkets
·
47 ນາທີກ່ອນ
Here Are the Corporations Joining S&P 500
FXEmpire
·
1 ຊົ່ວໂມງກ່ອນ
Nasdaq 100 Forecast: 35,000 in View as Weak Jobs Ease Fed Hike Bets
WSJ
·
12 ຊົ່ວໂມງກ່ອນ
Nasdaq Leads Stocks Higher as Hiring Softens
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, ນິວເຈີຊີ, ສະຫະລັດ
SectorBiotechnology
Websitekalaristx.com